FDA approves first new kind of drug to target gonorrhea in decades The bacterium that causes gonorrhea has developed resistance to nearly every antibiotic used against it.

The #FDA just approved zoliflodacin, sold as #Nuzolvence, a new single-dose, oral pill to treat #gonorrhea in people 12 and up 🧪💊. It gives doctors and patients a much-needed, easier option against a sexually transmitted infection that’s been getting tougher to treat with older antibiotics ✨

💊FDA Approval Update | #FDA recently approved #Nuzolvence (#Zoliflodacin) and #Blujepa (#Gepotidacin)
👉For uncomplicated urogenital #gonorrhea
🌟MedChemExpress provides zoliflodacin and gepotidacin for research use only